Funding
Featured Initiatives
Ongoing Programs
Phased Innovation Awards (PIA) fund exploratory projects to bring new concepts into the research and development "pipeline."
HIV Vaccine Research and Design (HIVRAD) program advances concepts further towards the development of a prophylactic AIDS vaccine.
Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) supports the later stages of preventive HIV/AIDS vaccine concept refinement and testing, culminating in human studies.
HIV Vaccine Design and Development Teams (HVDDT) fund consortia of scientists with development experience from industry and/or academia that have identified a promising vaccine concept and envisioned a product worthy of targeted development.
Highly Innovative Tactics to Interrupt Transmission of HIV (HIT-IT) funds research on novel, unconventional, outside-the-box, high-risk, and/or potential high-impact approaches that may provide long-term, safe protection from HIV infection.
Basic HIV Vaccine Discovery Research funds research to identify new concepts and approaches that will inform the design of an optimal prophylactic HIV vaccine design, and implement concepts and/or approaches employed successfully in the development of vaccines for other infections.
back to top